C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/12 (2006.01) A61K 31/423 (2006.01) A61P 1/06 (2006.01) A61P 1/08 (2006.01) C07D 451/04 (2006.01) C07D 451/14 (2006.01) C07D 453/02 (2006.01) C07D 498/08 (2006.01)
Patent
CA 2597962
Compounds of formulae (I) and (II) are disclosed as 5-HT3inhibitors. Those compounds that exhibit central activity are useful in treating chemotherapy- induced nausea and vomiting (CINV); those that peripheral receptors are useful to treat diarrhea-predominant Irritable Bowel Syndrome (IBS-D).
L'invention porte sur des composés de formule (I) et (II), inhibiteurs du 5-HT3 . Lesdits composés, qui présentent une activité centrale, s'avèrent utiles pour traiter les nausées et vomissements dus à la chimiothérapie (CINV); et ceux qui présentent des récepteurs périphériques, le syndrome de l'intestin irritable à prédominance diarrhée (IBS-D).
Fairfax David J.
Yang Zhicai
Albany Molecular Research Inc.
Amr Technology Inc.
Cassan Maclean
LandOfFree
Benzoxazole carboxamides for treating cinv and ibs-d does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzoxazole carboxamides for treating cinv and ibs-d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoxazole carboxamides for treating cinv and ibs-d will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1993824